The Ventripoint – GE PartnershipGood DD
@TDGAFAU https://cdn-ceo-ca.s3.amazonaws.com/1j02l7h-1huppni-GEHealthcare_Ventripoint_Intel_Briefing_20230208%20-%20Copy%20%281%29.pdf The Ventripoint – GE Partnership
Though details of the partnership have been kept under wraps, it is possible to make inferences about
how the relationship came to be – and perhaps the significance of it - based on the academics who have
studied the VMS+ and direct connections to cardiac ultrasound innovation at GE.
The ProCardio Center for Innovation in Oslo appears to have a significant partnership with GE
Healthcare with the goal of advancing cardiac technology through the Edison program1
. Ventripoint is an
Edison Partner2
. ProCardio is located in at the Rikshospitalet in Oslo, the site of a Ventripoint VMS+
placement3
.
The VMS+ has been studied by persons at the hospital including H. Brun4
, and senior cardiologists
associated to Rikshospitalet/ProCardio have direct relationships to persons who use/study VMS+.
Examples include leaders of ProCardio: Edvardsen who has published with Brun and authored at least 5
papers with Mertens (one of VMS+’s most prolific researchers); and Samset who has published with
Almeida5
. Based on LinkedIn and other open-source information, Samset appears to have a significant
senior role at GE in the advancement of innovative AI cardiology technology through the Edison
program6
. Almeida is particularly noteworthy as he published a paper that included a review of VMS+
and as of 2022 worked at GE Vingmed in Norway. GE’s Norway location appears to be a major hub for
its cardiac ultrasound business7
. Furthermore, a VMS+3.0 was placed King’s College London8
and key
user Monaghan has published with both Samset and Almeida9
.
Another significant link is that the GE Norway official quoted in the Ventripoint/GE release (Mcleod) has
also published with Brun (VMS+ researcher). Put a different way, the person initially chosen to represent
this relationship for GE had a direct previous connection to VMS. It is possible, given the timing of
Mcleod’s presence at ProCardio10, that this expert could have had direct experience using the
technology.
GE Healthcare is active on Linkedin and produces a significant amount of training content involving
cardiologists11. Ventripoint Clinical Advisor Banchs12 is involved in GE echocardiography training.
Similarly experts Delgado and Sitges have written chapters1314 in echocardiography textbooks that have
discussed VMS (aka Knowledge-Based Reconstruction) and both appear to be involved in GE echo
training.
What does this mean? The information summarized above and in the associated chart suggests that a
major research institution/hospital (ProCardio/Rikshospitalet) responsible for the advancement of
1 Annual-report-2021-FINAL.pdf (heart-sfi.no)
2 Ventripoint Collaborates with GE Healthcare to Bring More Functionality to its Cardiac Ultrasound Devices (thenewswire.com)
3 VentriPoint Diagnostics Ltd. (VPTDF) Technology Now Used by Hospitals around the World - QualityStocks
4 Ventripoint VMS(TM) Heart Analysis System Used to Monitor Therapy in Pulmonary Hypertension and Valve Replacement in Congenital Heart
Disease (yahoo.com)
5 Left atrial volumetric assessment using a novel automated framework for 3D echocardiography: a multi-centre analysis - PubMed (nih.gov)
6 GE Healthcare, American College of Cardiology unite toward AI-powered cardiac care | Healthcare IT News
7 GE sees strong future with its ultrasound business (jsonline.com)
8 Kings College London Receives VMS+3.0 Ventripoint Whole Heart Analysis System (thenewswire.com)
9 Left atrial volumetric assessment using a novel automated framework for 3D echocardiography: a multi-centre analysis - PubMed (nih.gov)
10 SFI CCI Final Report, trykk.pdf (heart-sfi.no)
11 LinkedIn searches for “GE Healthcare”, filtered by posts
12 Ventripoint Welcomes Dr. Jose Banchs as New Clinical Advisor (thenewswire.com)
13Assessing the Right Ventricle | SpringerLink
14 Speckle Tracking | 18A | v3 | 3D Echocardiography | Nicolas Duchateau, (taylorfrancis.com)
cardiac technology for GE has experts (some of whom also work for GE) who were already likely familiar
with VMS prior to the Ventrpoint-GE announcement, both through the placement of the device at the
facility and via direct relationships with other cardiac experts who use/publish on VMS. Given the
absence of information on the partnership, this analysis could suggest that the relationship is credible
and significant, considering the number and quality of experts familiar with Ventripoint, and closely
linked to GE.
PLEASE READ: The information shown above and in the associated chart is based on extensive searches
of publicly available information from academic publications, LinkedIn, and websites. The analysis does
not make any predictions about the future direction/success of Ventripoint, and the inferences made
are highly speculative and could be incorrect.
Author: